cyc 202 has been researched along with mirabegron in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (mirabegron) | Trials (mirabegron) | Recent Studies (post-2010) (mirabegron) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 558 | 131 | 538 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boucher, J; Harms, M; Maurer, S | 1 |
1 review(s) available for cyc 202 and mirabegron
| Article | Year |
|---|---|
The colorful versatility of adipocytes: white-to-brown transdifferentiation and its therapeutic potential in humans.
Topics: Acetanilides; Adipocytes, Beige; Adipocytes, Brown; Adipocytes, White; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Cell Lineage; Cell Transdifferentiation; Diabetes Mellitus; Drugs, Investigational; Energy Metabolism; Humans; Imatinib Mesylate; Obesity; Roscovitine; Thermogenesis; Thiazoles | 2021 |